Related Experiment Video
Updated: May 21, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI
Mario Torso1, Pegah Khosropanah1, Steven A Chance1
1Oxford Brain Diagnostics Ltd, Oxford, UK.
Background:
This study evaluates the capability of cortical microstructural measures from diffusion magnetic resonance imaging (MRI) to predict progression from mild cognitive impairment (MCI) to dementia, compared to commonly used macrostructural measures. Identification of high-risk individuals can support both clinical practice and trials.
Methods:
Structural and diffusion MRI scans of 826 participants from the National Alzheimer's Coordinating Center (NACC) were analyzed to extract macrostructural measures and three minicolumn-related diffusivity metrics: AngleR, PerpPD+, and ParlPD. Kaplan-Meier survival analysis was used to investigate time to progression to dementia, with participants stratified by biomarker metrics.
Results:
Cortical diffusivity (PerpPD+ in medial-temporal and connected regions) outperformed hippocampal volume, cortical volume, and cortical thickness in Kaplan-Meier survival analysis, predicting faster conversion to dementia.
Discussion:
Cortical microstructural measures from diffusion MRI provide powerful biomarkers for predicting progression from MCI to dementia, offering enhanced prognostic capabilities that could support earlier intervention strategies in clinical practice and improve the power of clinical trials.
Highlights:
Cortical minicolumn-related diffusivity metrics measure neurodegeneration. We compare the predictive value of magnetic resonance imaging (MRI) measures for mild cognitive impairment to dementia progression. Microstructural cortical disarray outperforms macrostructural markers. These results support using diffusion MRI biomarkers to identify and monitor at-risk patients.
Insights
Diffusion MRI microstructural measures, like cortical diffusivity, better predict mild cognitive impairment (MCI) to dementia progression than traditional MRI measures. This aids early intervention and clinical trials for at-risk individuals.
Area of Science:
- Neuroimaging
- Biomarkers
- Neurodegeneration
Background:
- Mild cognitive impairment (MCI) is a precursor to dementia.
- Accurate prediction of MCI to dementia progression is crucial for clinical practice and trials.
- Current predictive markers often rely on macrostructural MRI measures.
Purpose of the Study:
- To evaluate the predictive capability of cortical microstructural measures from diffusion MRI.
- To compare diffusion MRI microstructural measures against traditional macrostructural MRI measures for predicting dementia progression.
- To identify individuals at high risk for dementia for earlier intervention.
Main Methods:
- Analysis of structural and diffusion MRI scans from 826 National Alzheimer's Coordinating Center (NACC) participants.
- Extraction of macrostructural measures (e.g., volume, thickness) and minicolumn-related diffusivity metrics (AngleR, PerpPD+, ParlPD).
- Kaplan-Meier survival analysis to assess time to dementia conversion, stratified by biomarker metrics.
Main Results:
- Cortical diffusivity (PerpPD+ in medial-temporal and connected regions) demonstrated superior predictive performance.
- Diffusion MRI microstructural measures outperformed hippocampal volume, cortical volume, and cortical thickness.
- Individuals with specific diffusivity patterns showed faster conversion to dementia.
Conclusions:
- Cortical microstructural measures from diffusion MRI serve as powerful biomarkers for predicting MCI to dementia progression.
- These microstructural markers offer enhanced prognostic capabilities compared to macrostructural markers.
- Diffusion MRI biomarkers can aid in identifying and monitoring at-risk patients, improving clinical trial power and enabling earlier interventions.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction

